Suppr超能文献

使用铁羧麦芽糖进行肾移植血管系统的磁共振血管造影:高分辨率稳态与首过采集的比较。

MR Angiography of Renal Transplant Vasculature with Ferumoxytol:: Comparison of High-Resolution Steady-State and First-Pass Acquisitions.

作者信息

Corwin Michael T, Fananapazir Ghaneh, Chaudhari Abhijit J

机构信息

Department of Radiology, University of California, Davis Medical Center, 4860 Y Street, Suite 3100, Sacramento, California 95817, USA.

Department of Radiology, University of California, Davis Medical Center, 4860 Y Street, Suite 3100, Sacramento, California 95817, USA.

出版信息

Acad Radiol. 2016 Mar;23(3):368-73. doi: 10.1016/j.acra.2015.10.021. Epub 2015 Dec 18.

Abstract

RATIONALE AND OBJECTIVES

This work aimed to quantify the differences in signal-to-noise ratio (SNR) and vessel sharpness between steady-state and first-pass magnetic resonance angiography (MRA) with ferumoxytol in renal transplant recipients.

MATERIALS AND METHODS

We performed a retrospective study of adult patients who underwent steady-state and first-pass MRA with ferumoxytol to evaluate renal transplant vasculature. SNR was calculated in the external iliac artery, and vessel sharpness was calculated in the external iliac and renal transplant arteries for both acquisitions. Data were compared using Student's t test.

RESULTS

Fifteen patients were included (mean age 56.9 years, 10 males). The mean SNR of the external iliac artery was 42.2 (SD, 11.9) for the first-pass MRA and 41.8 (SD, 9.7) for the steady-state MRA (p = 0.92). The mean vessel sharpness was significantly higher for the steady-state MRA compared to first-pass MRA for both external iliac (1.24 vs. 0.80 mm(-1), p < 0.01) and renal transplant arteries (1.26 vs. 0.79 mm(-1), p < 0.01).

CONCLUSION

Steady-state MRA using ferumoxytol improves vessel sharpness while maintaining equivalent SNR compared to conventional first-pass MRA in renal transplant patients.

摘要

原理与目的

本研究旨在量化肾移植受者使用菲洛多酸进行稳态磁共振血管造影(MRA)和首过MRA时的信噪比(SNR)及血管清晰度差异。

材料与方法

我们对成年患者进行了一项回顾性研究,这些患者接受了使用菲洛多酸的稳态和首过MRA以评估肾移植血管系统。在双侧髂外动脉计算SNR,并在两次采集时分别在双侧髂外动脉和肾移植动脉计算血管清晰度。数据采用学生t检验进行比较。

结果

纳入15例患者(平均年龄56.9岁,男性10例)。首过MRA时双侧髂外动脉的平均SNR为42.2(标准差11.9),稳态MRA时为41.8(标准差9.7)(p = 0.92)。对于双侧髂外动脉(1.24对0.80 mm⁻¹,p < 0.01)和肾移植动脉(1.26对0.79 mm⁻¹,p < 0.01),稳态MRA的平均血管清晰度均显著高于首过MRA。

结论

在肾移植患者中,与传统首过MRA相比,使用菲洛多酸的稳态MRA可提高血管清晰度,同时保持相当的SNR。

相似文献

2
Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
Transplantation. 2013 Jul 15;96(1):91-6. doi: 10.1097/TP.0b013e318295464c.
4
5
Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.
Eur Radiol. 2018 Jan;28(1):115-123. doi: 10.1007/s00330-017-4934-5. Epub 2017 Jul 4.

引用本文的文献

2
Advancing MRI with magnetic nanoparticles: a comprehensive review of translational research and clinical trials.
Nanoscale Adv. 2024 Apr 2;6(9):2234-2259. doi: 10.1039/d3na01064c. eCollection 2024 Apr 30.
3
The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts.
Abdom Radiol (NY). 2024 Aug;49(8):2858-2872. doi: 10.1007/s00261-024-04268-x. Epub 2024 Apr 1.
6
Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art.
AJR Am J Roentgenol. 2023 Apr;220(4):590-603. doi: 10.2214/AJR.22.28453. Epub 2022 Oct 5.
7
Contrast-enhanced MR Angiography without Gadolinium-based Contrast Material: Clinical Applications Using Ferumoxytol.
Radiol Cardiothorac Imaging. 2022 Aug 4;4(4):e210323. doi: 10.1148/ryct.210323. eCollection 2022 Aug.
8
Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.
Abdom Radiol (NY). 2021 May;46(5):2203-2218. doi: 10.1007/s00261-020-02817-8. Epub 2020 Oct 22.
9
MRI for diagnosis of post-renal transplant complications: current state-of-the-art and future perspectives.
MAGMA. 2020 Feb;33(1):49-61. doi: 10.1007/s10334-019-00813-8. Epub 2019 Dec 26.
10
Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.
Eur Radiol. 2019 Jul;29(7):3543-3552. doi: 10.1007/s00330-019-06137-4. Epub 2019 Mar 27.

本文引用的文献

1
Vascular Imaging With Ferumoxytol as a Contrast Agent.
AJR Am J Roentgenol. 2015 Sep;205(3):W366-73. doi: 10.2214/AJR.15.14534. Epub 2015 Jun 23.
2
Anaphylaxis with elevated serum tryptase after administration of intravenous ferumoxytol.
NDT Plus. 2010 Aug;3(4):341-2. doi: 10.1093/ndtplus/sfq084. Epub 2010 May 11.
3
Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
Pediatr Radiol. 2015 Jun;45(6):831-9. doi: 10.1007/s00247-014-3226-3. Epub 2014 Nov 27.
4
Emerging applications for ferumoxytol as a contrast agent in MRI.
J Magn Reson Imaging. 2015 Apr;41(4):884-98. doi: 10.1002/jmri.24691. Epub 2014 Jun 30.
5
Vascular artifact mimicking thrombosis on MR imaging using ferumoxytol as a contrast agent in abdominal vascular assessment.
J Vasc Interv Radiol. 2014 Jun;25(6):969-76. doi: 10.1016/j.jvir.2013.12.019. Epub 2014 Mar 14.
8
Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
Transplantation. 2013 Jul 15;96(1):91-6. doi: 10.1097/TP.0b013e318295464c.
9
USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure.
Radiology. 2012 Nov;265(2):584-90. doi: 10.1148/radiol.12112694. Epub 2012 Aug 8.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验